Please upgrade your browser.
Prognostic factors from the Memorial Sloan Kettering Cancer Center (MSKCC) model plus 2 additional factors are valid predictors of overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)-targeted agents.
Patients with poor-risk renal cell carcinoma have improved survival with temsirolimus (Torisel) whether they have a nephrectomy or not.
The Society of Interventional Radiology (SIR) will present the latest research on treatments for individuals with kidney, prostate and bone cancer; herniated disks; peripheral arterial disease (PAD) and related complications; childbirth difficulties; and more at its 34th Annual Scientific Meeting, March 7-12.
272-Patient Phase 2 Data Show 91.7 Percent Disease Control Rate and Favorable Tolerability; Interim Results Being Presented at ASCO GU Indicate Highly Differentiated VEGFR Profile
Large-scale data mining of gene networks in fruit flies has led University of Chicago researchers to a sensitive and specific diagnostic biomarker for human renal cell carcinoma.
The tax revolt, partly inspired by CNBC reporter Rick Santelli's rant earlier this week about President Barack Obama's housing rescue plan, resulted in a grassroots effort pushing "tea party" protests Friday in large cities like Los Angeles, Chicago, Atlanta and Houston, and small towns like Tulsa, Iowa, and Calera, Ala.
It is the first in its class shown to consistently deliver improved overall and/or progression-free survival benefit for colorectal, lung, breast and, renal cell cancer patients.
Accounting for all those factors, one prominent study places the total for the long-term uninsured as low as 8.2 million a very different reality than the media and national health care advocates claim.
When his father was diagnosed with terminal kidney cancer in 2003, East Pennsboro Township resident Scott Shirley turned his fear and frustration into an iron-pumping fundraiser he called Lift for Life.
Association of German Medical Journalists and Bayer HealthCare honor outstanding reporting on renal cancer.
|Powered by NeonCRM|